These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28597249)

  • 1. Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation.
    Meyer-Roxlau S; Lämmle S; Opitz A; Künzel S; Joos JP; Neef S; Sekeres K; Sossalla S; Schöndube F; Alexiou K; Maier LS; Dobrev D; Guan K; Weber S; El-Armouche A
    Basic Res Cardiol; 2017 Jul; 112(4):43. PubMed ID: 28597249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic Reticulum Stress Is Associated With Autophagy and Cardiomyocyte Remodeling in Experimental and Human Atrial Fibrillation.
    Wiersma M; Meijering RAM; Qi XY; Zhang D; Liu T; Hoogstra-Berends F; Sibon OCM; Henning RH; Nattel S; Brundel BJJM
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload.
    Grote-Wessels S; Baba HA; Boknik P; El-Armouche A; Fabritz L; Gillmann HJ; Kucerova D; Matus M; Müller FU; Neumann J; Schmitz M; Stümpel F; Theilmeier G; Wohlschlaeger J; Schmitz W; Kirchhefer U
    Cardiovasc Res; 2008 Aug; 79(3):464-71. PubMed ID: 18453636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex functionality of protein phosphatase 1 isoforms in the heart.
    Liu R
    Cell Signal; 2021 Sep; 85():110059. PubMed ID: 34062239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein phosphatase 1 by a selective phosphatase disrupting peptide reduces sarcoplasmic reticulum Ca
    Fischer TH; Eiringhaus J; Dybkova N; Saadatmand A; Pabel S; Weber S; Wang Y; Köhn M; Tirilomis T; Ljubojevic S; Renner A; Gummert J; Maier LS; Hasenfuß G; El-Armouche A; Sossalla S
    Eur J Heart Fail; 2018 Dec; 20(12):1673-1685. PubMed ID: 30191648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines.
    George I; Sabbah HN; Xu K; Wang N; Wang J
    Cardiovasc Res; 2011 Aug; 91(3):447-55. PubMed ID: 21493701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation.
    Perike S; Gonzalez-Gonzalez FJ; Abu-Taha I; Damen FW; Hanft LM; Lizama KS; Aboonabi A; Capote AE; Aguilar-Sanchez Y; Levin B; Han Z; Sridhar A; Grand J; Martin J; Akar JG; Warren CM; Solaro RJ; Ong SG; Darbar D; McDonald KS; Goergen CJ; Wolska BM; Dobrev D; Wehrens XHT; McCauley MD
    Circ Res; 2023 Oct; 133(9):758-771. PubMed ID: 37737016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.
    Chiang DY; Alsina KM; Corradini E; Fitzpatrick M; Ni L; Lahiri SK; Reynolds JO; Pan X; Scott L; Heck AJR; Wehrens XHT
    Circulation; 2018 Oct; 138(15):1569-1581. PubMed ID: 29669786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
    Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
    PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts.
    Gupta RC; Mishra S; Rastogi S; Imai M; Habib O; Sabbah HN
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2373-81. PubMed ID: 14613911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Simpson J; Castagno D; Doughty RN; Poppe KK; Earle N; Squire I; Richards M; Andersson B; Ezekowitz JA; Komajda M; Petrie MC; McAlister FA; Gamble GD; Whalley GA; McMurray JJ;
    Eur J Heart Fail; 2015 Nov; 17(11):1182-91. PubMed ID: 26358762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential localizations of protein phosphatase 1 isoforms determine their physiological function in the heart.
    Liu R; Miller C; D'Annibale C; Vo K; Jacobs A
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):323-330. PubMed ID: 30721967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta-blocker therapy in heart failure and atrial fibrillation.
    Fung JW; Yu CM; Kum LC; Yip GW; Sanderson JE
    Card Electrophysiol Rev; 2003 Sep; 7(3):236-42. PubMed ID: 14739721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control.
    Avitall B; Bi J; Mykytsey A; Chicos A
    Heart Rhythm; 2008 Jun; 5(6):839-45. PubMed ID: 18534368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PP1-12, a novel protein phosphatase-1 inhibitor, on ventricular function and remodeling after myocardial infarction in rats.
    He YY; Liu CL; Li X; Zhong W; Li S; He KL; Wang LL
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):360-7. PubMed ID: 25286361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart.
    Dally S; Monceau V; Corvazier E; Bredoux R; Raies A; Bobe R; del Monte F; Enouf J
    Cell Calcium; 2009 Feb; 45(2):144-54. PubMed ID: 18947868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.